From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

about

From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

Item

http://www.wikidata.org/entity/Q47736824

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

@en

From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

@nl

type

Item

label

From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

@en

From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

@nl

prefLabel

From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

@en

From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

@nl

P1476

From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome.

@en

P2093

Aurélie Champigny

http://www.w3.org/2001/XMLSchema#string

Daniel A Thomas

http://www.w3.org/2001/XMLSchema#string

Ian R Baldwin

http://www.w3.org/2001/XMLSchema#string

Joelle Le

http://www.w3.org/2001/XMLSchema#string

Laura M Inglesby

http://www.w3.org/2001/XMLSchema#string

Paul Faulder

http://www.w3.org/2001/XMLSchema#string

Simon Gaines

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Washio

http://www.w3.org/2001/XMLSchema#string

Zoë A Henley

http://www.w3.org/2001/XMLSchema#string

P2860

Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors

PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers

Potent and selective inhibitors of PI3Kδ: obtaining isoform selectivity from the affinity pocket and tryptophan shelf

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease

The phosphoinositide 3-kinase pathway

PI3Kgamma inhibition: towards an 'aspirin of the 21st century'?

The emerging mechanisms of isoform-specific PI3K signalling

Fighting tumor cell survival: advances in the design and evaluation of Pim inhibitors.

Kinase drug discovery--what's next in the field?

Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism.

P304

1093-1098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.7B00296

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ben Bax

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29057057

http://www.w3.org/2001/XMLSchema#string

P921

Kinome

P932

5642016

http://www.w3.org/2001/XMLSchema#string